Geovax to present at the 2024 bio ceo & investor conference

Atlanta, ga, feb. 19, 2024 (globe newswire) -- via newmediawire – geovax labs, inc. (nasdaq: govx), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced today that its chairman and ceo, david dodd, will present at the 2024 bio ceo & investor conference, taking place in-person in new york, ny on february 26-27, 2024.

GOVX Ratings Summary

GOVX Quant Ranking